HEALTHCARE VENTURES
HealthCare Ventures is a leading life science venture capital firm investing in pre-clinical or early clinical stage, focused companies with potential to transform patient care.
HEALTHCARE VENTURES
Social Links:
Industry:
Finance Financial Services Venture Capital
Founded:
1985-01-01
Status:
Active
Contact:
617-252-4343
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail
Similar Organizations
Converge
Converge is a venture capital firm that specializes in seed, startup, early Series A, and early-stage investments.
Headline
Headline is a global venture capital firm investing in winning teams across stages and geographies.
Henkel Ventures
Henkel Ventures is Henkel's corporate venture capital engagement, combining all venture activities across the company’s business units.
Obvious Ventures
Obvious Ventures is a venture capital firm that invests in the early and growth stages.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-09-14 | Colorescience | HealthCare Ventures investment in Debt Financing - Colorescience | 30 M USD |
| 2016-01-01 | Leap Therapeutics | HealthCare Ventures investment in Venture Round - Leap Therapeutics | N/A |
| 2015-09-08 | Proteostasis Therapeutics | HealthCare Ventures investment in Series B - Proteostasis Therapeutics | 37 M USD |
| 2015-06-11 | Galleon Pharmaceuticals | HealthCare Ventures investment in Series B - Galleon Pharmaceuticals | 10 M USD |
| 2015-02-10 | Vaxxas | HealthCare Ventures investment in Series B - Vaxxas | 25 M USD |
| 2014-09-10 | Colorescience | HealthCare Ventures investment in Series B - Colorescience | 15 M USD |
| 2014-06-05 | Senseonics | HealthCare Ventures investment in Venture Round - Senseonics | 20 M USD |
| 2013-10-30 | Pathogenetix | HealthCare Ventures investment in Series C - Pathogenetix | 10 M USD |
| 2013-04-01 | Catalyst Biosciences | HealthCare Ventures investment in Post-IPO Equity - Catalyst Biosciences | 5.07 M USD |
| 2013-03-25 | Theraclone Sciences | HealthCare Ventures investment in Series B - Theraclone Sciences | 8 M USD |